Associated Papers
AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance.
O'Hare T et al.
Cancer Cell, 2009
Select a paper to view details
O'Hare T et al.
Cancer Cell, 2009